← GE HealthCare Technologies Inc.

	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Net income	$2.3b	$2.0b	$1.6b	$2.0b	$2.2b
Net income from continuing operations	$2.3b	$1.9b	$1.6b	$2.0b	$2.2b
Less: Income (loss) from discontinued operations, net of taxes	$18.0m	$18.0m	($4.0m)	$0	$0
Cash from (used for) operating activities – continuing operations	$1.6b	$2.1b	$2.1b	$2.0b	$2.0b
Cash from (used for) investing activities – continuing operations	($1.8b)	($398.0m)	($558.0m)	($914.0m)	($1.0b)
Cash from (used for) financing activities – continuing operations	($263.0m)	($822.0m)	($478.0m)	($573.0m)	$617.0m
Cash from (used for) operating activities – discontinued operations	$0	($21.0m)	$0	($4.0m)	$0
Depreciation of property, plant, and equipment	$225.0m	$228.0m	$248.0m	$268.0m	$287.0m
Amortization of intangible assets	$400.0m	$405.0m	$362.0m	$312.0m	$291.0m
Share-based compensation	$76.0m	$67.0m	$114.0m	$125.0m	$130.0m
Gain on remeasurement of Nihon Medi-Physics equity method investment	—	—	$0	$0	($97.0m)
Net periodic postretirement benefit plan (income) expense	$25.0m	$9.0m	($332.0m)	($357.0m)	($267.0m)
Postretirement plan contributions	($20.0m)	($18.0m)	($357.0m)	($332.0m)	($338.0m)
Provision for income taxes	$600.0m	$563.0m	$743.0m	$531.0m	$614.0m
Receivables	($1.3b)	($231.0m)	($185.0m)	($178.0m)	($216.0m)
Inventories	($435.0m)	($402.0m)	$111.0m	($81.0m)	($142.0m)
Contract and other deferred assets	$23.0m	($222.0m)	$10.0m	$3.0m	($60.0m)
Accounts payable	$263.0m	$481.0m	($13.0m)	$126.0m	$90.0m
Contract liabilities	($21.0m)	$138.0m	$26.0m	$68.0m	$81.0m
Current compensation and benefits	—	($37.0m)	$153.0m	$39.0m	$94.0m
All other operating activities – net	$11.0m	$103.0m	$327.0m	($74.0m)	($204.0m)
Net increase (decrease) in borrowings (maturities of 90 days or less)	($7.0m)	$9.0m	($12.0m)	$0	$1.0m
Repayments and other reductions (maturities longer than 90 days)	($10.0m)	($3.0m)	($855.0m)	($1.4b)	($1.8b)
Net transfers (to) from GE	($238.0m)	($8.9b)	($1.3b)	$0	$0
Proceeds from stock issued under employee benefit plans	—	$0	$34.0m	$33.0m	$37.0m
Additions to property, plant and equipment and internal-use software	($248.0m)	($310.0m)	($387.0m)	($401.0m)	($482.0m)
Dispositions of property, plant, and equipment	$15.0m	$4.0m	$1.0m	$0	$0
Acquired but unpaid property, plant, and equipment	$93.0m	$136.0m	$140.0m	$143.0m	$164.0m
Purchases of businesses, net of cash acquired	($1.5b)	$0	($147.0m)	($313.0m)	($378.0m)
Purchases of investments	—	($59.0m)	($48.0m)	($40.0m)	($118.0m)
All other investing activities – net	($47.0m)	($92.0m)	($25.0m)	($160.0m)	($69.0m)
Newly issued debt, net of debt issuance costs (maturities longer than 90 days)	$5.0m	$8.2b	$2.0b	$995.0m	$2.7b
Repurchase of common stock	—	—	$0	$0	($200.0m)
Redemption of noncontrolling interests	$0	$0	($211.0m)	$0	$0
Dividends paid to stockholders	$0	$0	($41.0m)	($55.0m)	($64.0m)
All other financing activities – net	($13.0m)	($92.0m)	($48.0m)	($34.0m)	($81.0m)
Increase (decrease) in cash, cash equivalents, and restricted cash	($451.0m)	$890.0m	$1.1b	$387.0m	$1.6b
Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash	($34.0m)	($3.0m)	($10.0m)	($77.0m)	$66.0m
Cash, cash equivalents, and restricted cash at beginning of year	$561.0m	$1.5b	$2.5b	$2.9b	$4.5b
Cash paid during the year for interest	($21.0m)	$0	($570.0m)	($550.0m)	($522.0m)
Cash paid during the year for income taxes	($615.0m)	($851.0m)	($474.0m)	($491.0m)	($429.0m)
Taxes paid related to net share settlement of equity awards	($615.0m)	$0	($33.0m)	($93.0m)	($42.0m)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.